ONCOCYTE CORP (OCX)

US68235C2061 - Common Stock

2.93  -0.14 (-4.56%)

After market: 2.82 -0.11 (-3.75%)

News Image
4 days ago - InvestorPlace

OCX Stock Earnings: OncoCyte Misses EPS, Misses Revenue for Q1 2024

OCX stock results show that OncoCyte missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.

News Image
4 days ago - BusinessInsider

OCX Stock Earnings: OncoCyte Misses EPS, Misses Revenue for Q1 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips OncoCyte (NASDAQ:OCX) just reported results for the first quarter of 2024.OncoC...

News Image
4 days ago - OncoCyte Corporation

Oncocyte Reports First Quarter 2024 Financial Results

ONCOCYTE REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS...

News Image
a month ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

We are starting the trading week with a dive into the biggest pre-market stock movers worth keeping tabs on for Monday morning!

News Image
a month ago - InvestorPlace

OCX Stock Earnings: OncoCyte Misses EPS, Misses Revenue for Q4 2023

OCX stock results show that OncoCyte missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.

News Image
a month ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Friday is here and we're starting the final day of trading this week with a breakdown of the biggest pre-market stock movers this morning!

News Image
a month ago - OncoCyte Corporation

Oncocyte Reports Full Year 2023 Financial Results

ONCOCYTE REPORTS FULL YEAR 2023 FINANCIAL RESULTS...

News Image
a month ago - OncoCyte Corporation

Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules

Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules...

News Image
a month ago - OncoCyte Corporation

Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay

Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay...

News Image
a month ago - OncoCyte Corporation

Oncocyte to Announce Fourth Quarter and Full Year 2024 Financial Results

ONCOCYTE TO ANNOUNCE FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS...

News Image
6 months ago - OncoCyte Corporation

Oncocyte Begins FDA Submissions Process for VitaGraft Transplant Assays

- Significant unmet need for regulated product in $2B US testing market - Opportunity for expedited pathway for kitted product in development IRVINE,...

News Image
6 months ago - OncoCyte Corporation

Oncocyte Reports Third Quarter 2023 Financial Results

-Launching First Products in 1H 2024- -Conference Call on Thursday, November 9, 2023 at 5:00 a.m. PT / 8:00 a.m. ET- IRVINE, Calif., Nov. 09, 2023 ...

News Image
7 months ago - OncoCyte Corporation

Oncocyte to Announce Third Quarter 2023 Financial Results

Conference Call and Webcast on Thursday, November 9, 2023, at 5:00 a.m. PT / 8:00 a.m. ...

News Image
10 months ago - Oncocyte Corporation

VitaGraft Kidney Expands Utility in Recurrent Primary Disease Patients

- Blood-based test differentiates between ABMR and IgAN, enabling faster and more effective treatment- Improved utility over standard of care tests- Paper...

News Image
10 months ago - Oncocyte Corporation

Oncocyte Announces 1-For-20 Reverse Stock Split

IRVINE, Calif., July 24, 2023 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX) (the “Company”), a precision diagnostics company, announced today...

News Image
a year ago - Oncocyte Corporation

Oncocyte Begins Manufacturing Transplant Blood Test

Over 1 million annual testing opportunities in US Q4 targeted for early access launch IRVINE, Calif., June 27, 2023 (GLOBE NEWSWIRE) -- Oncocyte...

News Image
a year ago - Oncocyte Corporation

Oncocyte Reports First Quarter 2023 Financial Results

Nearing Manufacturing Start Up of First Kitted Product...

News Image
a year ago - Oncocyte Corporation

Oncocyte To Announce First Quarter 2023 Financial Results

Conference Call on Thursday, May 11 at 6:00 a.m. PT / 9:00 a.m. ...

News Image
a year ago - Oncocyte Corporation

Oncocyte Presents New Data at AACR

IRVINE, Calif., April 18, 2023 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today announced that five posters...

News Image
a year ago - Seeking Alpha

Oncocyte stock gains on plans to cut 20% of staff (NASDAQ:OCX)

Oncocyte Corporation (OCX) announced plans to reduce about 20% of its workforce on Wednesday in an attempt to cut costs and extend its cash runway. Read more here.

News Image
a year ago - Oncocyte Corporation

Oncocyte Announces Reduction in Force

IRVINE, Calif., April 12, 2023 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today announced a reduction in...